---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-096519"
form_type: "8-K"
ticker: null
cik: "0001044378"
company_name: "BIOCEPT INC"
filed_at: "2023-04-10T23:59:59+00:00"
generated_at: "2026-06-17T03:59:17.388763+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Biocept issues Series B Preferred to Board Chair to secure reverse stock split approval

## Summary
- Issued one share of Series B Preferred to Chair Samuel Riccitelli for $100; carries 300M votes solely on reverse split proposals.
- Series B votes must mirror common stock votes cast (excluding abstentions/broker non-votes), effectively reducing impact of non-votes.
- Reverse split approval now requires majority of combined common + Series B voting power, altering prior majority-of-outstanding-common standard.
- Series B is non-convertible, has $100 liquidation preference senior to common, and is redeemed automatically after reverse split approval.
- Transfer restricted until reverse split vote; issuance exempt under Section 4(a)(2) as sale to accredited investor (Board Chair).

## SEC filing metadata
- accession: 0001193125-23-096519
- form_type: 8-K
- cik: 0001044378
- company_name: BIOCEPT INC
- filed_at: 2023-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1044378/000119312523096519/0001193125-23-096519-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1044378/000119312523096519/d470097d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-096519
- JSON: https://secwatch.observer/filing/0001193125-23-096519.json
- Plain text: https://secwatch.observer/filing/0001193125-23-096519.txt

## Key facts
- Governance Changes
  BIOCEPT INC: Filed Certificate of Designation for Series B Preferred Stock, establishing preferences, rights and limitations (effective 2023-04-10).
  - Change: charter amendment
  - Effective: 2023-04-10
  source text: On April 10, 2023, in connection with the Purchase Agreement, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock (the “Series B Certificate of Designation”) with the Secretary of State of the State of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1044378/000119312523096519/0001193125-23-096519-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.